<--- Back to Details
First PageDocument Content
Biology / Genentech / South San Francisco /  California / Bevacizumab / Organofluorides / HER2/neu / Trastuzumab emtansine / Trastuzumab / Rituximab / Pharmacology / Medicine / Orphan drugs
Date: 2010-12-08 08:04:38
Biology
Genentech
South San Francisco
California
Bevacizumab
Organofluorides
HER2/neu
Trastuzumab emtansine
Trastuzumab
Rituximab
Pharmacology
Medicine
Orphan drugs

09 Roche in Brief

Add to Reading List

Source URL: www.roche.com

Download Document from Source Website

File Size: 4,30 MB

Share Document on Facebook

Similar Documents

Napoleone Ferrara, Genentech

DocID: 1uIWu - View Document

Microsoft Word - Genentech 2010 ltr v2.doc

DocID: 1uy56 - View Document

U.S. Patent No. 7,838,512, Claims 1-3 & 5-6 Petition for Inter Partes Review Filed on behalf of OSI Pharmaceuticals, LLC and Genentech, Inc. By: David L. Cavanaugh, Reg. No. 36,476 (Lead Counsel) Wilmer Cutler Pickering

DocID: 1tr4e - View Document

Genentech / Hoffmann-La Roche / South San Francisco /  California / Pharmacology / Personalized medicine / Biology / California / Technology

Zermatt2016_final_program

DocID: 1r5GG - View Document

Biology / Evolutionary biology / Multicellular organism / Carlo Maley / Lunch / Evolution / Genentech / Breakfast / Mutation / Coffee

PDF Document

DocID: 1qP5u - View Document